“…Chitooligosaccharides (COS), the degraded products of chitosan or chitin, are oligomers of β-(1-4)-linked-d-glucosamine with remarkable biological activities at molecular and cellular levels. It has been reported that COS possess a wide range of biological activities, including anti-inflammatory (Huang et al, 2016;Molteni, Gemma, & Rossetti, 2016;Muanprasat et al, 2015;Paul-Clark et al, 2012), anti-obesity and lipid-lowering (Egan, Sweeney, Hayes, & O'Doherty, 2015;Pokhis, Bitterlich, Cornelli, & Cassano, 2015;Trivedi et al, 2016;Zou et al, 2016a), antidiabetic (Kondo, Nakatani, Hayashi, & Ito, 2000;Liu, Cai, & Chiang, 2015), antihypertensive (Huang, Mendis, & Kim, 2005;Ngo, Qian, Je, Kim, & Kim, 2008), immunostimulatory (Bahar, O'Doherty, Maher, McMorrow, & Sweeney, 2012;Seo et al, 2000;Xing et al, 2017;Zhang, Liu, Peng, Han, & Yang, 2014), and anticancer effects (Fernandes et al, 2012;Masuda et al, 2014;Mattaveewong et al, 2016;Muanprasat et al, 2015;Zou et al, 2016;Zou, Yuan, Yang, Zhai, & Wang, 2018). Among them, the enhancement of immune functions might be substantially effective to those suffering from declining immunity, such as the elderly people (Muanprasat & Chatsudthipong, 2017).…”